-
dedup_wf_001--6f7d8b6b8b7130937101f78d75f57ef7
Aims: The study evaluated real-world cost of treatment in multiple sclerosis (MS) patients initiating infused disease-modifying-therapies (DMT) in United States. Materials and... -
Natalizumab stabilizes physical, cognitive, MRI, and OCT markers of disease a...
Natalizumab is an effective therapy for multiple sclerosis (MS). Its effectiveness has been demonstrated in several clinical and imaging studies. The objective of this study was... -
r37980778c78--d43b7f24a8d9c6558799d6a408363c8d
Longitudinal clinical and imaging metrics over 96-week treatment period.